top of page

Chemo, Other Drug Prices Driven Up by 340B-Eligible Hospitals, Data Show

  • Writer: Leo Zini
    Leo Zini
  • Jan 25, 2024
  • 1 min read

An analysis of Blue Cross Blue Shield (BCBS) claims found that hospitals eligible for discounts under the federal 340B Drug Pricing Program marked up prices for physician-administered drugs, including chemotherapy, while keeping a large portion of total insurer spending for patients with private insurance. The findings, published online Jan. 25 in The New England Journal of Medicine, are in line with longstanding concerns that the 340B program is being misused...



 
 
iStock-1176975320.jpg

Community Action for Responsible Hospitals (CARH) is a non-profit organization of patient-focused stakeholders including labor unions, faith leaders, healthcare providers, consumer advocates, and public interest groups.

Thank you. Your message has been sent.

PRIVACY POLICY

TERMS OF USE

Community Action for Responsible Hospitals. © 2025 All Rights Reserved.

By providing my mobile number I consent to receive informational text messages from Community Action for Responsible Hospitals. Message frequency may vary. Msg & Data rates may apply. Donations will not be solicited. Text STOP to opt-out. Text HELP for help. For additional information, please see our Terms & Conditions and Privacy Policies. Mobile and opt-in data will not be shared with third parties.

bottom of page